Filing Details
- Accession Number:
- 0001127602-22-008106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-03 18:21:42
- Reporting Period:
- 2022-03-01
- Accepted Time:
- 2022-03-03 18:21:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1287981 | Jed John Kennedy | C/O Conmed Corporation 11311 Concept Boulevard Largo FL 33773 | Group Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-01 | 1,250 | $0.00 | 8,625 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-01 | 394 | $144.55 | 8,231 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2022-03-01 | 1,250 | $0.00 | 9,481 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-01 | 367 | $144.55 | 9,114 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2022-03-01 | 1,050 | $0.00 | 10,164 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-01 | 309 | $144.55 | 9,855 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2022-03-02 | 5,000 | $41.93 | 14,855 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-02 | 5,000 | $145.50 | 9,855 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-02 | 308 | $59.96 | 10,163 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-02 | 308 | $145.50 | 9,855 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-02 | 110 | $78.76 | 9,965 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-02 | 110 | $145.50 | 9,855 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Rsus (restricted Stock Units) | Disposition | 2022-03-01 | 1,250 | $0.00 | 1,250 | $0.00 |
| Common Stock | Rsus (restricted Stock Units) | Disposition | 2022-03-01 | 1,250 | $0.00 | 1,250 | $0.00 |
| Common Stock | Rsus (restricted Stock Units) | Disposition | 2022-03-01 | 1,050 | $0.00 | 1,050 | $0.00 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2022-03-02 | 5,000 | $0.00 | 5,000 | $41.93 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2022-03-02 | 308 | $0.00 | 308 | $59.96 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2022-03-02 | 110 | $0.00 | 110 | $78.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,250 | 2029-03-01 | No | 4 | M | Direct | |
| 2,500 | 2030-03-02 | No | 4 | M | Direct | |
| 3,150 | 2031-03-01 | No | 4 | M | Direct | |
| 0 | 2027-03-01 | No | 4 | M | Direct | |
| 10,492 | 2028-03-01 | No | 4 | M | Direct | |
| 5,590 | 2029-03-01 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Billionaire Hedge Funds
